ALPHAMAB ONCOLOGYALPHAMAB ONCOLOGYALPHAMAB ONCOLOGY

ALPHAMAB ONCOLOGY

No trades
See on Supercharts

9966 fundamentals

An in-depth look to ALPHAMAB ONCOLOGY operating, investing, and financing activities

9966 free cash flow for H1 24 is -19.08 M HKD. For 2023, 9966 free cash flow was -212.98 M HKD and operating cash flow was -173 M HKD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth